Does the Saskatchewan Drug Plan cover Ozempic for weight loss?

No. Coverage under Saskatchewan's Exception Drug Status process applies only to type 2 diabetes with documented clinical criteria; no Saskatchewan public program reimburses a GLP-1 for weight management.

What is the Special Support Program and does it help with GLP-1 costs?

It's Saskatchewan's income-based drug coverage program for residents without private insurance, covering a percentage of eligible costs, including approved GLP-1s, once household spending passes an income-linked threshold.

GLP-1 coverage in Saskatchewan

How the Saskatchewan Drug Plan's income-based programs apply to GLP-1 medications

Public plan

Saskatchewan Drug Plan

What the Saskatchewan Drug Plan covers

Saskatchewan's public drug coverage runs through several linked programs rather than a single formulary. Residents without private insurance can apply for the income-based Special Support Program, which covers a percentage of eligible drug costs, including approved GLP-1s, once household spending crosses a threshold tied to income; separate programs apply to seniors and people receiving income assistance.

GLP-1 medications such as Ozempic are covered under these programs when prescribed for type 2 diabetes and approved through the plan's Exception Drug Status process for restricted-listing drugs, which requires a prescriber to document that specific clinical criteria are met.

Why weight-loss GLP-1s aren't covered

Saskatchewan's Exception Drug Status approvals for semaglutide and tirzepatide are built around the diabetes indication. A prescription written for weight loss, whether for Wegovy, Saxenda, or an off-label use of a diabetes-approved GLP-1, doesn't meet the criteria and won't be reimbursed under the Special Support Program or any other Saskatchewan public plan.

This is consistent nationally: no provincial drug plan in Canada currently covers a GLP-1 prescribed specifically for weight management. Because criteria are reviewed periodically, confirm current rules with the Saskatchewan Drug Plan directly rather than assuming past denials still apply.

What you'll actually pay

Saskatchewan residents paying out of pocket, whether for a weight-loss prescription or while working through Special Support Program approval, will generally find Costco Pharmacy the cheapest dispensing option; a membership isn't required at the pharmacy counter. Generic semaglutide, available since the May 2026 Apotex and Dr. Reddy's launch, runs roughly $88 to $99/mo nationally, with province-specific Costco pricing here not independently verified.

Brand pricing at retail pharmacies runs considerably higher: Ozempic $250-$310/mo, Wegovy $400-$570/mo, Mounjaro $280-$550/mo, Zepbound $435-$550/mo. About 31% of employer private plans now cover GLP-1s for weight loss, and manufacturer savings cards can reduce brand costs for those with existing private insurance. Compounded GLP-1 products remain illegal in Canada.

Frequently asked

Does the Saskatchewan Drug Plan cover Ozempic for weight loss?: No. Coverage under Saskatchewan's Exception Drug Status process applies only to type 2 diabetes with documented clinical criteria; no Saskatchewan public program reimburses a GLP-1 for weight management.
What is the Special Support Program and does it help with GLP-1 costs?: It's Saskatchewan's income-based drug coverage program for residents without private insurance, covering a percentage of eligible costs, including approved GLP-1s, once household spending passes an income-linked threshold.